Replimune Group, Inc.
$4.610
USD
Last updated on --.
24h volume3.60M
24h highest5.0100 USD
24h lowest4.5050 USD
24h Price movement-6.11%
REPL recent prices
24 Hours
-6.11%-$0.3
30 days
+75.45%+$2.022
60 days
-32.13%-$2.320
90 days
-38.86%-$2.988
Key data
Previous close4.9100 USD
Market cap426.07M USD
Volume3.60M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-3.8100 USD
Net income (FY)-314.85M USD
Revenue (FY)--
Last report dateFeb 3, 2026
About Replimune Group, Inc.
HeadquartersWOBURN
Employees (FY)479.00
Net income per employee (FY)-657.31K USD
Listed onNasdaq
REPL conversion tables
 |  |
|---|---|
| 0.5 REPL | 2.305 USD |
| 1 REPL | 4.610 USD |
| 5 REPL | 23.05 USD |
| 10 REPL | 46.1 USD |
| |
|---|---|
| 0.5 USD | 0.10846 REPL |
| 1 USD | 0.21692 REPL |
| 5 USD | 1.084 REPL |
| 10 USD | 2.169 REPL |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
REPL is trading at $4.610, -6.11% over the last 24 hours. Track live moves on the price chart at the top of this page.
The REPL stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. REPL is currently trading at $4.610, -6.11% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on REPL price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. REPL's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from REPL; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against REPL's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Replimune Group, Inc.'s market cap is currently 426.07M USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume3.60M
24h highest5.0100 USD
24h lowest4.5050 USD
24h Price movement-6.11%
Start trade with REPL Perpetual
Sign up to trade